Clinical and prognostic significance of HIF-1α in glioma patients: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 12, 2015, Pages 22073-22083

  Liu, Qi ^a   Cao, Peicheng ^a  

^a WEIFANG PEOPLE'S HOSPITAL   (China)

Author keywords

Glioma; HIF 1 ; Meta analysis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

AGE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CARDIOVASCULAR PARAMETERS; GENDER; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MICROVASCULAR DENSITY; MULTICENTER STUDY; OVERALL SURVIVAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SURVIVAL TIME; SYSTEMATIC REVIEW; WORLD HEALTH ORGANIZATION;

EID: 84957110838     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Marumoto T and Saya H. Molecular biology of glioma, in Glioma. Springer; 2012. pp. 2-11.
2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
3. Jovčevska I, Kočevar N and Komel R. Glioma and glioblastoma‑how much do we (not) know? (Review). Mol Clin Oncol 2013; 1: 935-941.
4. Sehmer EA, Hall GJ, Greenberg DC, O’Hara C, Wallingford SC, Wright KA, Green AC. Incidence of glioma in a northwestern region of England, 2006-2010. Neuro Oncol 2014; 16: 971-4.
5. Houben M, Aben K, Teepen J, Schouten-Van Meeteren AY, Tijssen CC, Van Duijn CM, Coebergh JW. Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003. Acta Oncologica 2006; 45: 272-279.
6. Butowski NA and Berger M. Malignant Gliomas: Part I: Epidemiology, Risk Factors, Prognostic Factors, and Imaging Findings. Contemporary Neurosurgery 2012; 34: 1-5.
7. Efird JT. Epidemiology of Glioma. INTECH Open Access Publisher; 2011.
8. Nakazato Y. The 4th Edition of WHO Classification of Tumours of the Central Nervous System published in 2007. No Shinkei Geka 2008; 36: 473-91.
9. Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS. The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 2014; 16: 896-913.
10. Semenza GL. HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest 2013; 123: 3664-71.
11. Ryan HE, Lo J and Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005-15.
12. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90.
13. Minardi D, Lucarini G, Santoni M, Mazzucchelli R, Burattini L, Conti A, Principi E, Bianconi M, Scartozzi M, Milanese G, Di Primio R, Montironi R, Cascinu S, Muzzonigro G. Survival in Patients with Clear Cell Renal Cell Carcinoma Is Predicted by HIF-1α Expression. Anticancer Res 2015; 35: 433-438.
14. Reszec J, Hermanowicz A, Rutkowski R, Bernaczyk P, Mariak Z, Chyczewski L. Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema. J Neuro Oncol 2013; 115: 119-125.
15. Kaynar MY, Sanus GZ, Hnimoglu H, Kacira T, Kemerdere R, Atukeren P, Gumustas K, Canbaz B, Tanriverdi T. Expression of hypoxia inducible factor-1alpha in tumors of patients with glioblastoma multiforme and transitional meningioma. J Clin Neurosci 2008; 15: 1036-42.
16. Womeldorff M, Gillespie D and Jensen RL. Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus 2014; 37: E8.
17. Luo Z, Bai M, Xiao X, Zhang W, Liu X, Yang X, Li S, Huan Y, Wu Z, Zhang X, Cao W. Silencing of HIF-1alpha enhances the radiation sensitivity of human glioma growth in vitro and in vivo. Neuropharmacology 2015; 89: 168-74.
18. Yi L, Hou X, Zhou J, Xu L, Ouyang Q, Liang H, Zheng Z, Chen H, Xu M. HIF-1alpha genetic variants and protein expression confer the susceptibility and prognosis of gliomas. Neuromolecular Med 2014; 16: 578-86.
19. Kleihues P, Burger P and Scheithauer B. Histological Typing of Tumors of the Central Nervous System: World Health Organization International Histologic Classification of Tumors. Berlin: Springer-Verlag; 1993.
20. Wells G, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses [Internet], 2014. 2015.
21. Cao WD, Kawai N, Miyake K, Zhang X, Fei Z, Tamiya T. Relationship of 14-3-3zeta (ζ), HIF-1α, and VEGF expression in human brain gliomas. Brain Tumor Pathol 2014; 31: 1-10.
22. Liu Y, Li YM, Tian RF, Liu WP, Fei Z, Long QF, Wang XA, Zhang X. The expression and significance of HIF-1α and GLUT-3 in glioma. Brain Res 2009; 1304: 149-154.
23. Liao CC, Fan YH, Xiao B, Wu L, Zhu XG. The correlation between the expressions of hypoxiainducible factor-1α and centromere protein W in glioma tissues and cells. Tumor 2014; 34: 1045-1051.
24. Xing P, Lv Z, Zhang X, Yuan J. Expression and significance of HIF-1α, MGMT, CD133 in human glioblastoma. Chinese Journal of Clinicians Electronic Edition 2013; 7: 6258-6264.
25. Gao W, Guo K, Yu R, Pan X. Study of relativity between expressions of hypoxia-inducible factor-1 alpha and PCNA in human gliomas and prognosis of patients with gliomas. Chinese Journal of Clinical Neurosurgery 2004; 9: 354-356.
26. Fu K and Yuan X. The expression of HIF-1αand its relationship to apoptosis and prognostic significance in human glioma. Wuhan University 2005.
27. Wang G and Yang X. Study on the expression of HIF-1α and VEGF in human gliomas. Tianjin Medical University 2006.
28. Yin J, Zhao S, Fan S, Zhu X. Hypoxia inducible factor-1α expression in gliomas and its effect on prognosis. Hunan Medical Journal 2007; 18: 25-27.
29. Zheng K, Jiao B and Geng S. Expression of HIF-1α and VEGF in human glioma and their significance in the pathogenesis thereof. Journal of Brain and Nervous Diseases 2008; 16: 55-58.
30. Tan Y, Fang C, Sun H, Liu H. Expression and clinical significance of hypoxia inducible factor-1α and vascular endothlal growth factor in human gliomas. Shandong Medical Journal 2008; 48: 4-6.
31. Li L and Guo Z. The expressions of HIF-1α and nNOS in human cerebral glioma. Chinese Medical Sciences University 2008.
32. XXu X and Fan Z. The expression of hypoxia-inducible factor-1α and glucose transport-3 in human gliomas. Hebei Medical University 2008.
33. Liu Q, Sun G, Liu A, Zheng L, Xiong F. Relationship between expressions of HIF-1a and MMP-9 and angiogenesis and peritumorous edema of glioma. Chinese Journal of Cancer Prevention and Treatment 2009; 16: 1654-1656.
34. Li F and Yang X. The significance of HIF-1a, MMP-9, and VEGF expressions in gliomas. Acta Academiae Medicinae Xuzhou 2009; 29: 680-681.
35. Zhao S, Niu G and Tao S. Expression of ING4 and HIF-1a in human brain astrocytoma. Zhengzhou University 2010.
36. Wu W and Zhang Z. Expression and clinical significance of hypoxia inducible factor-1a in gliomas. Journal of Huaihai Medicine 2010; 28: 105-106.
37. Yu G, Ge X, Song Y, Fu R, Chen C. Study on relationship between the expression of HIF-1a and postoperative radiotherapy of glioma. Journal of Qiqihar Medical College 2010; 31: 3199-3201.
38. Zhang L, Liu Y and Yang F. Expression and clinical significance of HIF-1a in gliomas. Chinese Journal of Neurosurgical Disease Research 2010; 9: 325-327.
39. Li J and Yu G. The expression and their clinical significance of HIF-1a and Ki-67 in human brain gliomas. Chinese Medicine Guides 2011; 8: 21-23.
40. Zhang M, Fan H, Han X, Wang D. Expression of HIF-1a, MMP-2 and VEGF in gliomas and their relativity analysis. Cancer Research on Prevention and Treatment 2011; 38: 460-461.
41. Zhang H, Chu S, Ma Y, et al. The expression and significance of SLC22A18 and hypoxia-inducible facotr-1a in brain gliomas. Chinese Journal of Clinical Physicians 2011; 5: 4148-4151.
42. Jiang J, Lv Y, Ji Y, LI X. Significance and expressions of PTEN, Survivin and HIF-1a in gliomas. Chinese Journal of Cancer Prevention and Treatment 2012; 19: 1532-1534.
43. Xing P, Zhang X, Li J, Yuan J. Study on the relationship between the expression of HIF-1, MGMT and psot-operation chemotherapy in various grade glioma. Chinese Journal of Difficult and Complicated Cases 2013; 12: 852-854.
44. Liu X and Gu Y. The correlation and clinical significance of neuroglobin and HIF-1a expressed in gliomas. Zhongnan University 2013.
45. Diamond EL, Corner GW, De Rosa A, Breitbart W, Applebaum AJ. Prognostic awareness and communication of prognostic information in malignant glioma: a systematic review. J Neurooncol 2014; 119: 227-34.
46. Reardon DA and Wen PY. Glioma in 2014: Unravelling tumour heterogeneity-implications for therapy. Nat Rev Clin Oncol 2015; 12: 69-70.
47. Kaur B, Khwaja FW, Severson EA, Matheny SL, Brat DJ, Van Meir EG. Hypoxia and the hypoxiainducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005; 7: 134-53.
48. Zampell JC, Daluvoy S, Tomer A, Yan A, Mehrara BJ. HIF-1a regulates lymphangiogenic cytokine expression in chronic sterile inflammation. Journal of the American College of Surgeons 2011; 213: S97.
49. Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, Chang JY. The expression of HIF-1alpha in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep 2012; 39: 2021-9.
50. Zhu Cl, Huang Q, Liu CH, Lin XS, Xie F. Prognostic value of HIF-1α expression in patients with gastric cancer. Mol Biol Rep 2013; 40: 6055-6062.
51. Papatheodorou H, et al. Hypoxia inducing factor 1a (HIF-1a) expression in invasive breast cancer: correlation with tumor clinicopathological parameters. in Virchows Archiv. New York, NY 10013, USA: Springer 233 Spring ST; 2011.
52. Jensen RL, Ragel BT, Whang K, Gillespie D. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 2006; 78: 233-47.
53. Oliver L, Olivier C, Marhuenda FB, Campone M, Vallette FM. Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy. Curr Mol Pharmacol 2009; 2: 263-84.
54. Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang YJ, Zhao L, Chen FH, Wang XT, You QD, Guo QL. HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 2012; 19: 284-294.
55. Shen S, Kwan A, Chen Y, Wang Z. Effect of silencing HIF-1α on proliferation, invasion and migration of glioblastoma U87 cells. Neurol Sci 2013; 34: 365-371.
56. Mashiko R, Takano S, Ishikawa E, Yamamoto T, Nakai K, Matsumura A. Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image. J Neuro Oncol 2011; 102: 43-50.
57. Hong XY, Wang J and Li Z. AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma. Cell Biochem Biophys 2013; 67: 1487-1495.
58. Clara CA, Marie SK, de Almeida JR, Wakamatsu A, Oba-Shinjo SM, Uno M, Neville M, Rosemberg S. Angiogenesis and expression of PDGFC, VEGF, CD105 and HIF-1alpha in human glioblastoma. Neuropathology 2014; 34: 343-52.
59. Tanaka H, Sasayama T, Tanaka K, Nakamizo S, Nishihara M, Mizukawa K, Kohta M, Koyama J, Miyake S, Taniguchi M, Hosoda K, Kohmura E. MicroRNA-183 upregulates HIF-1alpha by tar geting isocitrate dehydrogenase 2 (IDH2) in glioma cells. J Neurooncol 2013; 111: 273-83.
60. Ji X, Wang H, Zhu J, Tang Y, Zhou Y, Zhu L, Gao C, Li W, You W, Yu B, Xia Q. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival. Neurol Res 2013; 35: 1044-1050.
61. Hu YY, Fu LA, Li SZ, Chen Y, Li JC, Han J, Liang L, Li L, Ji CC, Zheng MH, Han H. Hif-1α and Hif-2α differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells. Cancer Lett 2014; 349: 67-76.
62. Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D. Research Knock down of HIF-1α in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres. Mol Cancer 2010; 9: 133.